• FirefoxInstall the new Firefox »
  •  Dow Up 0.86% Nasdaq Up 0.90%

    Neurocrine Biosciences Inc. (NBIX)

    -NasdaqGS
    40.43 Up 1.38(3.53%) 4:00PM EST
    |After Hours : 40.43 0.00 (0.00%) 5:07PM EST
    Add to Portfolio
    Prev Close:39.05
    Open:39.30
    Bid:40.41 x 100
    Ask:N/A
    1y Target Est:41.00
    Beta:-0.92
    Earnings Date:Apr 28 - May 4 (Est.)
    Day's Range:39.29 - 40.60
    52wk Range:12.17 - 40.75
    Volume:1,001,235
    Avg Vol (3m):1,258,570
    Market Cap:3.12B
    P/E (ttm):N/A
    EPS (ttm):-0.81
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBIX

    Comparison

    Symbol% ChgMkt Cap
    NBIXUp 3.53%3.12B
    ABTDown 0.32%71.25B
    LLYUp 1.35%75.43B
    PFEUp 1.31%213.10B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:29-Dec-95

    Analysts

    Annual EPS Est (Dec-15) :-1.11
    Quarterly EPS Est (Mar-15) :-0.29
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-1.46

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback